VC firm
OrbiMed
Also known as OrbiMed Asia, OrbiMed Asia Partners II, LP, OrbiMed Israel Partners Limited Partnership
- Investor type
- VC
- Investing status
- Activeas of 2026-09-17Source (opens in a new tab)
- Headquarters
- New York, NY, United States
- Founded
- 1989
- Assets under management
- $20BStated by firm, as of 2026-09-17Source (opens in a new tab)
- Latest fund size
- $190MSEC amount soldSource (opens in a new tab)
- Funds
- 3
- orbimed.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Team page (opens in a new tab)
Claim, correct or request removal
Record updated 27 September 2026
About
OrbiMed is a global investment firm that invests in companies engaged in the discovery and development of biopharmaceutical products, medical technologies, medical devices, diagnostics, drug discovery tools, and healthcare information technology and services companies.
Investment approach
- Thesis
- OrbiMed seeks to invest globally in world-class healthcare companies to help drive innovation, address unmet medical needs, and improve patient outcomes.Source (opens in a new tab)
- Leads rounds
- Yes
- Lead policy
- OrbiMed is typically a lead investor, helping to build our portfolio companies into market leaders.
- Investing status notes
- OrbiMed seeks to invest globally in world-class healthcare companies to help drive innovation, address unmet medical needs, and improve patient outcomes.
Funds
- OrbiMed Asia Partners II, LP
- Vintage 2013Main fund
- OrbiMed Israel Partners Limited Partnership
- $190MVintage 2011, Main fund, SEC amount sold
- Healthcare Royalty & Credit Fund V
- $1.9BMain fund, Announced close
SEC registration
- SEC CIK
- 1517870, 1584561
Locations
- Headquarters
- New York, NY, United States
- Office
- Shanghai, China
- Office
- London, United Kingdom
- Office
- Hong Kong, Hong Kong
- Office
- Herzliya, Israel
- Office
- Mumbai, India
- Office
- South San Francisco, CA, United States
Loading relationship preview